Erratum

This article refers to:

Small Molecule Drug Discovery for Dengue and West Nile Viruses: Applying Experience from Hepatitis C Virus

Following the publication of the Review by Tanya Parkinson and David C Pryde ‘Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus’, in the July 2010 issue of Future Medicinal Chemistry (Future Med. Chem. 2[7], 1181–1203 [2010]), it has been brought to our attention that:

Table 1 on page 1183 was incorrectly printed as:

Table 1. Compounds in clinical development for hepatitis C virus.

Compound	Mechanism	Structure	Company	Stage
Telaprevir	Protease		Vertex	Phase III

This should have been printed as:

Table 1. Compounds in clinical development for hepatitis C virus.

Compound	Mechanism	Structure	Company	Stage
Telaprevir	Protease		Vertex	Phase III